BGC
ABBV icon

Blue Granite Capital’s AbbVie ABBV Stock Holding History

Blue Granite Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$634K Sell
6,585
-13,901
-68% -$1.31M 0.47% 30
2017
Q3 		$1.82M Sell
20,486
-31,769
-61% -$2.42M 1.26% 29
2017
Q2 		$3.79M Sell
52,255
-7,300
-12% -$491K 2.45% 5
2017
Q1 		$3.88M Buy
59,555
+5,100
+9% +$321K 2.54% 7
2016
Q4 		$3.41M Buy
+54,455
New +$3.32M 2.42% 8

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Blue Granite Capital's ABBV Position: Q4 2017 in Review

Blue Granite Capital reduced its AbbVie (ABBV) stake by 68% in Q4 2017, selling an estimated $1.31M and leaving 6,585 shares worth $634K. The position accounts for 0.47% of the portfolio, ranked #30.

Blue Granite Capital first reported a position in ABBV in Q4 2016 and has held it in 5 quarters since. The position peaked at $3.88M in Q1 2017. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Blue Granite Capital held 6,585 shares of AbbVie worth $634K as of Q4 2017.
  • Blue Granite Capital sold 13,901 AbbVie shares in Q4 2017, an estimated $1.31M.
  • AbbVie made up 0.47% of Blue Granite Capital's portfolio in Q4 2017, its #30 holding.
  • Blue Granite Capital first reported a position in AbbVie in Q4 2016 and has held it in 5 quarters since.
  • Blue Granite Capital's AbbVie position peaked at $3.88M in Q1 2017.
  • 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Blue Granite Capital's 13F filing for Q4 2017, filed 14 Feb 2018.